Engaged Capital LLC: EVOLENT HEALTH INC (EVH): Quarterly 13F Position History
As of Q1 2026, Engaged Capital LLC reported 5,563,912 shares of EVOLENT HEALTH INC (EVH), worth $12.7M and representing 4.2% of its 13F equity book. The position first appeared in Q3 2020 and has been disclosed across 23 13F-HR filings in Pactolio's tracked window.
- 5,563,912Shares Held (Latest Filing)
- $12.7MReported Market Value (Latest Filing)
- 4.2%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- -$9.6MQuarter-over-Quarter Value Change
- 8,553,155Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 23 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 5,563,912 | 0 | — | $12.7M | 4.2% | $2.3 |
| Q4 2025 | 5,563,912 | 100,000 | -1.8% | $22.3M | 5.7% | $4.0 |
| Q3 2025 | 5,663,912 | 190,556 | -3.3% | $47.9M | 11.8% | $8.5 |
| Q2 2025 | 5,854,468 | +675,000 | +13.0% | $65.9M | 18.4% | $11.3 |
| Q1 2025 | 5,179,468 | 225,300 | -4.2% | $49.0M | 12.5% | $9.5 |
| Q4 2024 | 5,404,768 | +1,415,300 | +35.5% | $60.8M | 12.5% | $11.3 |
| Q3 2024 | 3,989,468 | 121,990 | -3.0% | $112.8M | 18.3% | $28.3 |
| Q2 2024 | 4,111,458 | +850,000 | +26.1% | $78.6M | 13.5% | $19.1 |
| Q1 2024 | 3,261,458 | 0 | — | $106.9M | 17.3% | $32.8 |
| Q4 2023 | 3,261,458 | +428,648 | +15.1% | $107.7M | 15.8% | $33.0 |
| Q3 2023 | 2,832,810 | +1,085,558 | +62.1% | $77.1M | 14.1% | $27.2 |
| Q2 2023 | 1,747,252 | 466,202 | -21.1% | $52.9M | 7.7% | $30.3 |
| Q1 2023 | 2,213,454 | 572,588 | -20.6% | $71.8M | 10.2% | $32.5 |
| Q4 2022 | 2,786,042 | +544,050 | +24.3% | $78.2M | 13.2% | $28.1 |
| Q3 2022 | 2,241,992 | 3,912,829 | -63.6% | $80.6M | 15.9% | $35.9 |
| Q2 2022 | 6,154,821 | 991,574 | -13.9% | $189.0M | 29.0% | $30.7 |
| Q1 2022 | 7,146,395 | 683,297 | -8.7% | $230.8M | 23.4% | $32.3 |
| Q4 2021 | 7,829,692 | 63,502 | -0.8% | $216.6M | 26.7% | $27.7 |
| Q3 2021 | 7,893,194 | 659,961 | -7.7% | $244.7M | 17.6% | $31.0 |
| Q2 2021 | 8,553,155 | 0 | — | $180.6M | 14.0% | $21.1 |
| Q1 2021 | 8,553,155 | 0 | — | $172.8M | 12.5% | $20.2 |
| Q4 2020 | 8,553,155 | 0 | — | $137.1M | 11.3% | $16.0 |
| Q3 2020 | 8,553,155 | — | — | $106.1M | 11.0% | $12.4 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Engaged Capital LLC first disclose a EVH position in 13F-HR filings?
Engaged Capital LLC first reported EVOLENT HEALTH INC (EVH) on its 13F-HR filing for the period ending 2020-09-30 (Q3 2020). The position has appeared on 23 reported quarters within Pactolio's tracked window.
What was Engaged Capital LLC's most recent quarter-over-quarter share-count change in EVH?
Engaged Capital LLC held the same 5,563,912 shares of EVH between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent Engaged Capital LLC's cost basis in EVH?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.